Efficacy of Splinting, Exercise and Electrotherapy on Hallux Valgus

Sponsor
Ankara Yildirim Beyazıt University (Other)
Overall Status
Completed
CT.gov ID
NCT04393545
Collaborator
(none)
60
3
69

Study Details

Study Description

Brief Summary

The aim of this study was to investigate the effects of splinting, exercise and electrotherapy on the hallux valgus (HV) angle, and foot-specific health-related quality of life. Sixty women (120 feet) with bilateral HV deformity were randomly assigned to one of three groups - an HV night splint (SP) group, an exercise (EX) group, and a high-voltage galvanic stimulation (EL) group. Angular degrees (hallux interphalangeal, HV, and intermetatarsal angles expressed as angles A, B and C, respectively) were determined before enrollment (t0) and three months after treatment (t2). Foot-specific quality of life was assessed using the Manchester-Oxford Foot Questionnaire (MOFQ) at t0, after one month (t1), and at t2. All groups exhibited significant changes in the A, B, and C angles and outcome measures (p ≤0.001). Decreases in the A and C angles, and MOFQ-Pain subscale scores, were higher in the SP group than in the other two groups (p<0.05). C angle at t2, MOFQ-Walking score at t1 and t2 and MOFQ-Pain subscale score at t1 were lower in the SP group (p<0.05).

Condition or Disease Intervention/Treatment Phase
  • Device: hallux valgus night splint
  • Other: exercise
  • Other: Electrotherapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Comparison of the Effectiveness of Splinting, Exercise and Electrotherapy in the Management of Hallux Valgus: a Randomized Clinical Trial
Actual Study Start Date :
Feb 2, 2009
Actual Primary Completion Date :
Jul 7, 2014
Actual Study Completion Date :
Nov 3, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: HV night splint (SP) group

Device: hallux valgus night splint
The HV night splint holds the hallux in abduction in order to provide a correct position. The SP group was given splints consisting of a rigid polyethylene bar along the medial of the hallux, and soft polyform and Velcro fastener parts.

Active Comparator: exercise (EX) group

Other: exercise
The exercises involved strengthening the AbdH (abductor hallucis) and plantar fascia muscles, and stretching the hallux

Active Comparator: high-voltage galvanic stimulation (EL) group

Other: Electrotherapy
Two self-adhesive electrodes were used. One was placed over the medial distal end of the first metatarsal and the other was attached to the motor point of the AbdH (inferior and posterior to the navicular tuberosity).21 The stimulation intensity was increased until a contraction was observed without causing discomfort and pain. Twenty-minute HVPGS was applied in total over three weekly sessions for four weeks.

Outcome Measures

Primary Outcome Measures

  1. Manchester Scale [used once before enrollment for the inclusion]

    This scale determines the severity of HV and deformity using four foot photographs (0 'no deformity', 1 'mild', 2 'moderate' or 3: 'severe deformity').

  2. change in hallux valgus angle [were taken before enrollment and at three-month follow-up controls]

    Antero-posterior radiographs of patients' bilateral feet were taken before treatment and at three-month follow-up controls (in a standing position). HV, intermetatarsal, and hallux interphalangeal angles were measured on the radiographic images. These angles were abbreviated to angles A, B and C respectively.

  3. change in Manchester-Oxford Foot Questionnaire score [were assessed three times: before enrollment, at 1st and 3rd months.]

    MOFQ Foot health-related quality of life was evaluated using the MOFQ. This consists of three categories - pain, walking/standing, and social interaction. The MOFQ contains 16 items, each scored on a Likert scale between 0 and 4. Possible scores for each domain range from 0 to 100, with higher scores indicating the most severe conditions

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • a diagnosis of HV confirmed by an orthopedist experienced in foot surgery

  • female gender

  • bilateral HV deformity

  • aged 18-60 years.

  • Patients were then selected based on an HV deformity degree of '2' or '3' on the Manchester scale before randomization

Exclusion Criteria:
  • Patients with HV deformity degrees less than '2' or more than '3' according to the Manchester scale

  • Patients with systemic disease, cognitive or mental disturbance, a history of surgery to the lower extremity, or previous use of any foot splints were excluded.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Ankara Yildirim Beyazıt University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bahar Anaforoglu Külünkoglu, ASSOCIATE PROFESSOR, Ankara Yildirim Beyazıt University
ClinicalTrials.gov Identifier:
NCT04393545
Other Study ID Numbers:
  • KA08/143
First Posted:
May 19, 2020
Last Update Posted:
May 19, 2020
Last Verified:
May 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bahar Anaforoglu Külünkoglu, ASSOCIATE PROFESSOR, Ankara Yildirim Beyazıt University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2020